2-(2-(4-CHLORO-2-(TRIFLUOROMETHYL)PHENYL)DIAZENYL)-N-(2,3-DIHYDRO-2-OXO-1H-BENZIMIDAZOL-5-YL)-3-OXOBUTANAMIDE
UNII Q7UH985LDS
Substance Identification & Data
This profile provides standardized clinical and technical data for 2-(2-(4-chloro-2-(trifluoromethyl)phenyl)diazenyl)-n-(2,3-dihydro-2-oxo-1h-benzimidazol-5-yl)-3-oxobutanamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Q7UH985LDS.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 39951-83-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C18H13ClF3N5O3 AEASHRDYTBPWPD-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 2-(2-(4-chloro-2-(trifluoromethyl)phenyl)diazenyl)-n-(2,3-dihydro-2-oxo-1h-benzimidazol-5-yl)-3-oxobutanamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.